Clinical Trial Update: Angiotensin Converting Enzyme (ACE) Inhibition and Peripheral Arterial Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating ACE inhibition for Peripheral Arterial Disease has completed, reporting results from patients with PAD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• ACE inhibitors

Snippet

Sponsor: Bayside Health | Conditions: Peripheral Arterial Disease | Phase 4 | Status: COMPLETED